The role of interleukin-17 in murine cytomegalovirus interstitial pneumonia in mice with skin transplants

Transplant International

Volumn 24, Issue 8, 2011, Pages 845-855

  Zhao, Ji Qiang ^a   Chen, Li Zhong ^a   Qiu, Jiang ^a   Yang, Shi Cong ^a   Liu, Long Shan ^a   Chen, Guo Dong ^a   Zhang, Wei ^b   Ni, De Qun ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

interleukin 17; interstitial pneumonia; murine cytomegalovirus; skin transplantation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EMBRYO; FEMALE; HISTOLOGY; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN GRAFT; SPLEEN LYMPHOCYTE; TH17 CELL;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; LUNG DISEASES, INTERSTITIAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; SKIN TRANSPLANTATION; TIME FACTORS;

EID: 79960145018     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01273.x     Document Type: Article

References (48)

1. Tornatore KM, Garey KW, Saigal N, et al. Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clin Transplant 2001; 15: 297.
2. Farrugia E, Schwab TR,. Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 1992; 67: 879.
3. Daniel V, Pasker S, Wiesel M, et al. Cytokine monitoring of infection and rejection in renal transplant recipients. Transplant Proc 1995; 27: 884.
4. Nordøy I, Müller F, Nordal KP, et al. Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection. Clin Exp Immunol 2000; 120: 333.
5. Wu CA, Puddington L, Whiteley HE, et al. Murine cytomegalovirus infection alters Th1/Th2 cytokine expression, decreases airway eosinophilia, and enhances mucus production in allergic airway disease. J Immunol 2001; 167: 2798.
6. Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27: 779.
7. Loong CC, Hsieh HG, Lui WY, et al. Evidence for the early involvement of interleukin17 in human and experimental renal allograft rejection. J Pathol 2002; 197: 322.
8. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519.
9. Witowski J, Ksiazek K, Jörres A,. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 2004; 61: 567.
10. Molesworth-Kenyon SJ, Yin R, Oakes JE, et al. IL-17 receptor signaling influences virus-induced corneal inflammation. J Leukoc Biol 2008; 83: 401.
11. Hashimoto K, Durbin JE, Zhou W, et al. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol 2005; 116: 550.
12. Dubin PJ, Kolls JK,. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007; 292: L519.
13. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-β induces development of the T (H) 17 lineage. Nature 2006; 441: 231.
14. Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451: 211.
15. Palm NW, Medzhitov R,. Antifungal defense turn Th17. Nat Immunol 2007; 8: 549.
16. Arens R, Wang P, Sidney J, et al. Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 2008; 180: 6472.
17. McFarland HI, Rosenberg AS,. Skin allograft rejection. Curr Protoc Immunol 2009; 84: 4.4.1.
18. Price P, Hopkins RM, Teo HK, et al. Modulation of immunocompetence by cyclosporin A, cyclophosphamide or protein malnutrition potentiates murine cytomegalovirus pneumonitis. Pathol Res Pract 1991; 187: 993.
19. Hummel M, Zhang Z, Yan S, et al. Allergenic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol 2001; 75: 4814.
20. Shanley JD, Pesanti EL, Nugent KM,. The pathogenesis of pneumonitis due to murine cytomegalovirus. J Infect Dis 1982; 146: 388.
21. Min SI, Ha J, Park CG, et al. Sequential evolution of IL-17 responses in the early period of allograft rejection. Exp Mol Med 2009; 41: 707.
22. Yonemitsu J,. Interleukin-4 induces mouse cytomegalovirus interstitial pneumonia in a latent infection model. Kurume Med J 2001; 48: 49.
23. Orange JS, Biron CA,. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 1996; 156: 4746.
24. Kwun J, Knechtle SJ, Hu H,. Determination of the functional status of alloreactive T cells by interferon-[gamma] kinetics. Transplantation 2006; 81: 590.
25. + effector T cells develop via a lineage distinct from the T helper type 1and 2 lineages. Nat Immunol 2005; 6: 1123.
26. + T cells via down-regulation of PI3K/Akt and NF-kappaB. Immunol Lett 2007; 108: 88.
27. Zhang C, Zhang J, Yang B, et al. Cyclosporine A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. Cytokine 2008; 42: 345.
28. Liu X, Yang P, Lin X, et al. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-γ and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clin Immunol. 2009; 131: 333.
29. Chi W, Yang P, Zhu X, et al. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A. Mol Vis 2010; 16: 880.
30. Cervera C, Filella X, Linares L, et al. Th1/Th2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation. Transplant Proc 2007; 39: 2233.
31. Nakagiri T, Inoue M, Morii E, et al. Local IL-17 production and a decrease in peripheral blood regulatory T Cells in an animal model of bronchiolitis obliterans. Transplantation 2010; 89: 1312.
32. Weaver CT, Harrington LE, Mangan PR, et al. Th17: an effector CD4T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677.
33. Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448: 480.
34. Chen Z, Laurence A, O'Shea JJ,. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol 2007; 19: 400.
35. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875.
36. Atalar K, Afzali B, Lord G, et al. Relative roles of Th1 and Th17 effector cells in allograft rejection. Curr Opin Organ Transplant 2009; 14: 23.
37. Aggarwal S, Ghilardi N, Xie MH, et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278: 1910.
38. Reynaud-Gaubert M, Marin V, Thirion X, et al. Upregulation of chemokines in bronchoalveolar lavage fluid as apredictive marker of post-transplant airway obliteration. J Heart Lung Transplant 2002; 21: 721.
39. Hoshino H, Lötvall J, Skoogh BE, et al. Neutrophil recruitment by interleukin-17 into rat airways in vivo. Role of tachykinins. Am J Respir Crit Care Med 1999; 159: 1423.
40. Lindén A, Hoshino H, Laan M,. Airway neutrophils and interleukin-17. Eur Respir J 2000; 15: 973.
41. Nakano Y, Kasahara T, Mukaida N, et al. Protection against lethal bacterial infection in mice by monocyte-chemotactic and-activating factor. Infect Immun 1994; 62: 377.
42. Winter C, Herbold W, Maus R, et al. Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumonia. J Immunol 2009; 182: 4931.
43. Lemström K, Koskinen P, Krogerus L, et al. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation 1995; 92: 2594.
44. Lemström K, Sihvola R, Bruggeman C, et al. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation 1997; 95: 2614.
45. Orloff SL, Streblow DN, Soderberg-Naucler C, et al. Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. Transplantation 2002; 73: 679.
46. Streblow DN, Kreklywich C, Yin Q, et al. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol 2003; 77: 2182.
47. Carlquist JF, Shelby J, Shao YL, et al. Accelerated rejection of murine cardiac allografts by murine cytomegalovirus-infected recipients. Lack of heliotype specificity. J Clin Invest 1993; 91: 2602.
48. Shao YL, Shelby J, Hisatake G, et al. Accelerated cardiac allograft rejection in murine cytomegalovirus infected C3H recipients. Transplant Proc 1991; 23: 129.